03.06.2024 - By Levine Media Group
Brian Fiske, co-founder, chief scientific officer of Mythic Therapeutics, discusses the challenges that have held back the benefits of ADCs, how the company’s FateControl technology addresses those, and how it is thinking of building a pipeline of ADCs across indications.